Suven Life Sciences trades in green on the BSE

17 Aug 2021 Evaluate

Suven Life Sciences is currently trading at Rs. 84.25, up by 4.90 points or 6.18% from its previous closing of Rs. 79.35 on the BSE.

The scrip opened at Rs. 84.15 and has touched a high and low of Rs. 87.80 and Rs. 82.70 respectively. So far 204597 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 115.80 on 23-Apr-2021 and a 52 week low of Rs. 42.05 on 13-Nov-2020.

Last one week high and low of the scrip stood at Rs. 87.80 and Rs. 73.05 respectively. The current market cap of the company is Rs. 1078.08 crore.

The promoters holding in the company stood at 60.00%, while Institutions and Non-Institutions held 0.85% and 39.15% respectively.

Suven Life Sciences has planned initiation of Phase 3 clinical trial of SUVN-502 (Masupirdine), an antagonist for treatment of agitation and aggression in Alzheimer’s type dementias, with expected enrollment of patients from middle of September 2021. Its multi-center study (sites in the US and Europe) comprising about 387 patients is likely to be completed in about 36 months and the topline result expected by the end of year 2024.

SUVN-502 (Masupirdine), a lead clinical candidate having undergone phase 2 study on 564 patients for moderate Alzheimer's disease without meeting primary end point. After an in-depth analysis of the data and intense dialogue with key opinion leaders, we have planned a new Clinical Trial for the treatment of Agitation and aggression in Alzheimer's type dementias. Prior to the initiation of Phase 2A study, SUVN-502 has successfully undergone two phase 1 studies in Switzerland and USA on 122 healthy young and elderly male populations with no major adverse events and no serious adverse events.

Suven Life Sciences provides wide range of Drug Discovery and Development Support Services (DDDSS) to global Pharma and Biotech companies. Suven has state-of-art facilities with highly qualified & experienced team of scientists.

Suven Life Sciences Share Price

166.05 -1.75 (-1.04%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×